Connect with us

Emerging Markets

Maison Luxe Inc (OTCMKTS: MASN) on the Move Northbound as Luxury Retailer Reports Fast Growing Revenues

Published

on

Maison Luxe Inc (OTCMKTS: MASN) is running steadily northbound since reversing off $0.0026 lows reached in September. The stock got a boost on Tuesday after the Company announced it anticipates sequential revenue growth from approximately $1.5 million for the quarter ending June 30, 2022 to in excess of $3.5 million for the quarter ending September 30, 2022, an increase of more than 130%. Quarterly financials are expected to be released by November 15, 2022 and can be viewed at OTC Markets.  

Since acquiring Maison Luxe in early 2020, the Company has undergone a wholesale management and business model change and in April 2021 the Company changed its name and ticker symbol from CLKA to MASN. Maison Luxe has significantly expanded in the luxury goods space over the past 2 years, with new partnerships and contracts, and revenues have grown sharply. According to the Company’s OTCMarkets disclosure Maison Luxe did $17,635,898 for the year ended March 31, 2022 up from $5.2 million in 2021. 


Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Maison Luxe Inc (OTCMKTS: MASN) offers luxury retail consumer items. The Company operates as a niche high-end luxury goods retailer, helping interested consumers obtain rare luxury items that may otherwise not be available due to the nature of the luxury retail marketplace. The Company focuses its efforts primarily within the fine timepiece and jewelry segments, both on a wholesale and B2C (business-to-consumer) basis. Company subsidiary Amani Jewelers operates with a strategic focus on the rapidly growing lab-grown diamonds market. In addition, Maison Luxe holds a significant investment position in Aether Diamonds, which was founded in 2020 as the world’s first and only captured carbon lab-grown diamond producer. 

Earlier this year MASN partnered with Princess World Jewelers to retail a variety of luxury timepieces in their various brick and motor showrooms. Anchoring many luxury brand companies and fine jewelry, Princess World Jewelers has been an instrumental part of their local business community, servicing the estimated 2 million out-of-state visitors annually just in Alaska alone. According to the CLIA, “Some 58% of the 2 million out-of-state visitors in the summer of 2018 came to Alaska via a cruise ship. Direct visitor spending totals nearly $2.2 billion annually, excluding fares paid to travel (air, cruises, etc.).” 

To Find out the inside Scoop on MASN Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

MASN

On October 18 MASN reported it anticipates sequential revenue growth from approximately $1.5 million for the quarter ending June 30, 2022 to in excess of $3.5 million for the quarter ending September 30, 2022, an increase of more than 130%. Quarterly financials are expected to be released by November 15, 2022 and can be viewed at OTC Markets.  

Revenue in the Luxury Goods market is expected to exceed US $312.60 billion in 2022 and the market is expected to grow by 5.40% annually (CAGR 2022-2027). Maison Luxe’s current CAGR is projected to be greater than the industry average primarily due to execution of the Company’s business, sales and marketing plan which continues to nurture a growing pipeline of new and repeat customers. Maison Luxe offers excellent products, competitive pricing, on time deliveries and friendly and supportive customer service. 

Anil Idnani, CEO of Maison Luxe, stated, “We are pleased to announce our preliminary revenue numbers for the quarter ended September 30, 2022.  We continue to execute on our business plan and are pursuing new and complementary sources of revenue such as our recently announced luxury sneaker e-commerce division, Kicks on Demand.” 

For More on MASN Subscribe Right Now!

Currently trading at an under $1 million market valuation MASN is a low floater that is starting to get noticed by investors. MASN OS is 133,153,403 with 17.7 million shares in the float and a fairly healthy balance sheet with $3.5 million in assets vs. $4.5 million in liabilities. In 2020 the Company affected a 25,000 for 1 reverse stock split and on April 21, 2021 the ticker changed from CLKA to MASN. The stock has seen significant dilution which has decimated the share price to a sub $1 million valuation leading many speculators to see MASN has significantly oversold and undervalued at current levels. We will be updating MASN as events unfold so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in MASN either long or short and we have not been compensated for this article.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Is today’s surge in MMTec Inc (NASDAQ: MTC) justified ?

Published

on

MMTec, Inc. (NASDAQ: MTC) ended the day at $2.0700 with a gain of $0.5800 (+38.93%). The stock prices fluctuated between $1.4000 - $2.5299, with more than 2.98M shares exchanging hands.

MMTec, Inc. (NASDAQ: MTC) ended the day at $2.0700 with a gain of $0.5800 (+38.93%). The stock prices fluctuated between $1.4000 – $2.5299, with more than 2.98M shares exchanging hands.

So why did MTC surge today ?

The failure of Silicon Valley Bank led to a sell-off in equities and a shift to safe-haven assets, such as US Treasuries and gold. Markets have calmed down somewhat, and the worst of the equity sell-off seems to be over. However, the market anticipates that the markets will be somewhat uneasy until a better understanding of inflation is reached and what the Federal Reserve will do next week.

To Find out the inside Scoop on MTC, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Despite most investors currently avoiding the banking sector, Wall Street sees potential opportunities, particularly in regional banks. The chaos in the market has created opportunities in the industry and several banking stocks are being punished just for being a banking stock. The collapse of Silicon Valley Bank was due to its specialisation in venture-capital financing, which made it vulnerable to the higher interest rate regime of the past 12 months.

For more on MTC Subscribe Right Now!

Therfore, today’s gains in MTC seems to be more a sympathy bounce considering the overall banking sector. Earlier in March, MMTEC, Inc. (Nasdaq: MTC) declared that it will relocate its operations from Beijing to the Hong Kong Special Administrative Region, effective March 6, 2023. The Company’s subsidiary, MM Future Technology Limited, which is a Hong Kong incorporated limited company, will assume all operations previously conducted by its subsidiary, Gujia (Beijing) Technology Co., Ltd. However, Gujia will continue to carry out specific technical research and development functions. Further, the Company, through its subsidiary HC Securities (HK) Limited, and other entities, will continue to invest its human resources in asset management and securities underwriting, and other related businesses, aiming to attract global funds to invest in the Chinese market and support China’s economic growth. The Company’s new operations headquarters is located at Room 2302, 23rd Floor, FWD Financial Center, 308 Des Voeux Road Central, Sheung Wan, Hong Kong.

We will be updating on MTC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MTC.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have no position in MTC and have not been compensated for this article.

Continue Reading

Emerging Markets

Cazoo Group Ltd (CZOO) is one stock that Wall Street could be talking for day to come

Published

on

Cazoo Group Ltd (NASDAQ: CZOO) last traded at $2.62, a gain of +0.6400 (+32.32%). More than 5M shares exchanged hands compared to an average daily volume of 228K shares. Considering that the 52 week high of CZOO is more than 65$, there seems to be a lot of room to the upside.

To Find out the inside Scoop on CZOO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Why did CZOO surge last week? Welcome to the Carvana of the UK!

Cazoo, a publicly traded company (NYSE: CZOO), was founded in 2018 by serial entrepreneur Alex Chesterman OBE. The company’s mission is to revolutionize the UK’s car buying and selling experience by offering consumers better selection, value, transparency, convenience, and peace of mind. Cazoo’s goal is to make the car buying or selling process as simple as purchasing any other product online. The company enables customers to buy, sell, or finance a car entirely online, with delivery or collection available in as little as 72 hours.

Recently, Cazoo Group Ltd, the UK’s leading online car retailer, updated its business performance and progress with the restructuring announced in January. The CEO, Alex Chesterman, expressed satisfaction with the progress made so far in 2023, despite the challenging economic environment. The company has taken swift and decisive management action to restructure the group, improve unit economics, and reduce fixed costs. The rightsizing of headcount and operational footprint is well underway, and the company expects to complete the restructuring before the end of Q1 2023. The company has seen significant improvement in its GPU, with retail GPU tracking at approximately £900, up from £600 in Q4 2022. Cazoo has sold over 100,000 cars entirely online in the UK in the three years since its launch. The company remains fully focused on driving higher profitability and has appointed Jonathan Dunkley as Chief Operating Officer. Cazoo’s cash reserves remain strong, and the company expects to achieve profitability without external funding until H2 2024. The company expects to end 2023 with over £100m of cash and cash equivalents on its balance sheet and sell 40,000-50,000 UK retail units in the current year.

For more on CZOO, Subscribe Right Now!

The online car market in the UK has been growing rapidly in recent years, driven by increasing consumer demand for convenience and transparency in the car buying process. Online car retailers such as Cazoo, Carzam, and Cinch have emerged as major players in the market, offering a wide selection of used cars for sale online with home delivery or pickup options. These companies use advanced technology to provide customers with a seamless buying experience, including virtual vehicle inspections, transparent pricing, and easy financing options. The COVID-19 pandemic has further accelerated the shift towards online car buying as consumers seek to avoid in-person interactions and dealerships adapt to new ways of doing business.

So if CZOO learns from Carvana’s mistake, there is little to no doubt that CZOO could be the talk of the town in days to come. We will be updating on CZOO when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CZOO.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in CZOO, either long or short, and we have not been compensated for this article

Continue Reading

Emerging Markets

Ocean Biomedical Stock Surge could just be getting started and here’s why

Published

on

Shares of Ocean Biomedical (NASDAQ:OCEA) surged more than 100% on Thursday, following a talk by the company’s scientific co-founder, Dr. Jack A. Elias, at Brown University’s Legorreta Cancer Center. The preclinical-stage biotech, which went public on the NASDAQ on February 15, focuses on developing novel treatments for deadly diseases, including malaria, multiple cancers, and pulmonary fibrosis.

During the talk, Dr. Elias presented exciting details about potential therapies to suppress tumors in various cancers, focusing on the company’s work in understanding the role of the protein Chitinase 3-like-1 (CHI3LI) in the progression of lung cancer. He also discussed his discoveries on how certain monospecific and bispecific antibodies can be used as therapies to treat non-small cell lung cancer (NSCLC) and glioblastoma multiforme (GBM). The company aims to expedite these findings into phase 1 trials.

To Find out the inside Scoop on OCEA, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The excitement over this preliminary news stems from the large target groups for both diseases. According to Cancer.net statistics, NSCLC is the leading cause of cancer death and the second-most diagnosed cancer in the US, affecting around 236,740 people. GBM is the most common primary brain tumor in adults, with an average survival period of just 15 months and no cure.

The recent surge in Ocean Biomedical’s shares also comes on the heels of an announcement on February 28 that co-founder Dr. Jonathan Kurtis had been awarded a patent for the discovery of the third parasite target PfCDPK-5. This target has the potential to be used to halt the malaria parasite in various stages of its cycle, opening up new possibilities for treating this deadly disease.

Ocean Biomedical’s focus on developing novel treatments for deadly diseases and its recent exciting findings have generated significant investor interest. However, it is important to note that investing in preclinical-stage biotech companies carries a high level of risk. There is no guarantee that these discoveries will translate into effective treatments or that the company will receive regulatory approval.

For more on OCEA Subscribe Right Now!

Nevertheless, the positive developments from Ocean Biomedical are a significant milestone and hold great promise for patients suffering from deadly diseases such as cancer and malaria. If the company’s discoveries prove successful in further clinical trials, they could potentially generate significant revenue and transform the standard of care for these diseases. We will be updating on OCEA when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with OCEA.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in OCEA, either long or short, and we have not been compensated for this article

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.